PLUS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Plus Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Plus Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $106K, a 54.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $106K -$126K -54.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $139K -$103K -42.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $171K -$99K -36.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $202K -$46K -18.5% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $232K -$43K -15.6% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $242K -$61K -20.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $270K -$46K -14.6% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 $248K -$93K -27.3% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $275K -$284K -50.8% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 $303K -$335K -52.5% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 $316K -$284K -47.3% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 $341K -$295K -46.4% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $559K -$112K -16.7% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 $638K -$69K -9.76% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $600K -$144K -19.4% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $636K -$145K -18.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $671K -$147K -18% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $707K -$198K -21.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $744K -$379K -33.7% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $781K Dec 31, 2019 10-K 2021-02-22
Q3 2019 $818K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $905K Jun 30, 2019 10-Q 2019-08-15
Q1 2019 $1.12M Mar 31, 2019 8-K 2019-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.